IL23A and psoriasis: Figure reproduced with permission from Crowley et al. “Safety of selective IL-23p19 inhibitors for the treatment of psoriasis,” the Journal of the European Academy of Dermatology and Venereology, published by John Wiley & Sons Ltd. Hoboken, USA, 2019.